SCHEMBL23068177

SCHEMBL23068177

CCc1ccc(CCNC(=S)NC(=O)c2ccccc2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.81
▸ ALOX12 P18054 8/20 0.81
▸ SMN1; SMN2 Q16637 3/20 0.66
▸ HPGD P15428 1/20 0.66
▸ KCNH2 Q12809 1/20 0.63
▸ CYP1A2 P05177 2/20 0.62
▸ CYP3A4 P08684 2/20 0.62
▸ CYP2C9 P11712 2/20 0.62
▸ CYP2C19 P33261 2/20 0.62
▸ MEN1 O00255 2/20 0.62
▸ KMT2A Q03164 2/20 0.62
▸ CYP2D6 P10635 1/20 0.62
▸ MAPT P10636 1/20 0.62
▸ NPSR1 Q6W5P4 1/20 0.62
▸ POLB P06746 1/20 0.60
▸ RAB9A P51151 4/20 0.59
▸ MITF O75030 1/20 0.58
▸ NPC1 O15118 1/20 0.57
▸ LMNA P02545 1/20 0.56
▸ RECQL P46063 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15434970 0.90 ALDH1A1 (1.00) ALDH1A1ALOX12SMN1; SMN2HPGDKCNH2
SCHEMBL12069271 0.89 ALDH1A1 (0.81) ALDH1A1ALOX12SMN1; SMN2HPGDKCNH2
SCHEMBL21357791 0.87 ALDH1A1 (0.83) ALDH1A1ALOX12SMN1; SMN2HPGDKCNH2
SCHEMBL14859923 0.86 ALDH1A1 (0.81) ALDH1A1ALOX12SMN1; SMN2HPGDKCNH2
SCHEMBL12069268 0.86 ALDH1A1 (0.81) ALDH1A1ALOX12SMN1; SMN2HPGDKCNH2
SCHEMBL14946919 0.82 ALDH1A1 (0.69) ALDH1A1ALOX12SMN1; SMN2HPGDCYP1A2
SCHEMBL15328470 0.82 ALDH1A1 (0.78) ALDH1A1ALOX12SMN1; SMN2KCNH2CYP1A2
SCHEMBL23068164 0.81 ALDH1A1 (0.83) ALDH1A1ALOX12SMN1; SMN2KCNH2CYP1A2
SCHEMBL14859224 0.81 ALDH1A1 (0.77) ALDH1A1ALOX12SMN1; SMN2HPGDKCNH2
SCHEMBL13439903 0.81 RAB9A (0.74) SMN1; SMN2MEN1KMT2AMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814366-B2 Antiviral compounds and use thereof UNIVERSITA DEGLI STUDI DI SIENA (IT) 2023-11-14 — — US disclosed
EP-3765454-B1 ANTIVIRAL COMPOUNDS AND USE THEREOF UNIV DEGLI STUDI DI SIENA (IT) 2023-11-08 — — EP disclosed
US-20210070737-A1 ANTIVIRAL COMPOUNDS AND USE THEREOF UNIVERSITA DEGLE STUDI DI SIENA (IT) 2021-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11814366-B2 Antiviral compounds and use thereof MAVS, EIF2AK2, SARS1 ALDH1A1 2154/4885ALOX12 2331/4885SMN1; SMN2 2276/4885
US-20210070737-A1 ANTIVIRAL COMPOUNDS AND USE THEREOF MAVS, EIF2AK2, SARS1 ALDH1A1 2154/4885ALOX12 2331/4885SMN1; SMN2 2276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback